Recent Finacing
Recent Raise
QR Pharma is a clinical-stage pharma developing Posiphen, an inhibitor of neurotoxic protein synthesis, and BNC, advancing Phase II and preclinical programs for Alzheimer's, Parkinson's, Huntington's, glaucoma and TBI.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors